Skip to main content
Loading
  • Starttime
    • 9:15 AM
    • 9:30 AM
    • 9:45 AM
    • 10:00 AM
    • 10:15 AM
    • 10:30 AM
    • 10:45 AM
    • 11:00 AM
    • 11:15 AM
    • 11:30 AM
    • 11:45 AM
  • Date
    • October 18, 2023
9:15 AM
    • Gene/Cell Therapy
    Franciscan B
    Company Description: GelMEDIX is a seed-stage, Harvard/UCLA founded, cell therapy company focused on overcoming the fundamental challenges of current retinal cell therapy technologies to create vision ...
    • Oncology
    Franciscan C
    Company Description: Actym Therapeutics has engineered a new drug modality harnessing the power of a genetically modified bacterial vehicle that safely introduces therapeutic payloads to activate the ...
9:30 AM
    • Oncology
    Franciscan C
    Allterum Therapeutics is a Fannin-founded biopharmaceutical company targeting the IL-7 pathway for the treatment of patients with Acute Lymphoblastic Leukemia (ALL) and other cancers expressing CD127 ...
    • CNS/Neurological
    Franciscan B
    Company Description: LEVERaging RNA regulatory mechanisms to drug the undruggable with RNA-targeted therapeutics. We identify novel target RNA biology and design targeted therapeutics to increase, inh ...
    • Infectious Diseases
    Franciscan D
    Company Description: A preclinical stage biotech company in anti-infectives space, developing safer and efficacious biologics therapies against serious invasive fungal infections. Supported by a propr ...
9:45 AM
    • Oncology
    Franciscan C
    Pinetree Therapeutics is a biotechnology developing novel medicines to combat drug resistance in oncology and beyond. Pinetree's platform technology AbReptor™ is a first and best-in-class, transformat ...
    • Regenerative Medicine
    Franciscan D
    Company Description: Spry Bio, Inc. is a pre-clinical biotechnology company developing Optimized Platelet Therapies (OPTs) for treating osteoarthritis (OA) and other medical conditions characterized b ...
    • Oncology
    Franciscan B
    Company Description: We are a biotech company that has been developing new drugs by focusing on the protein degrader field since 2016/2017. About 50 people are working together in Korea, the United St ...
10:00 AM
    • Ophthalmology
    Franciscan D
    ViAn Therapeutics is developing an antiangiogenic peptidic drug for topical application in high-impact retinal diseases (DR, DME, AMD). Besides the non-invasive administration, this drug can stabilize ...
    • Oncology
    Franciscan C
    Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and development of novel oncology drugs that target the DNA damage response (DDR) in cancer cells.
    • CNS/Neurological
    Franciscan B
    Company Description: Monument Tx is a clinical stage neuroscience-specialist drug development company. Taking our cue from oncology, we aim to radically reduce drug development timeframes, and increas ...
10:15 AM
    • Ophthalmology
    Franciscan D
    Drusolv Therapeutics is a clinical-stage drug company based in Philadelphia. We are repurposing oral atorvastatin (using a novel formulation) for the new indication of early intervention in age-relate ...
    • CNS/Neurological
    Franciscan B
    Scioto Biosciences leverages discovery to improve lives. Good bacteria in our bodies have the potential to promote health and treat disease. Science suggests now that many disorders previously not con ...
    • Oncology
    Franciscan C
    Mobilizing endogenous bi-specific Natural-Killer T-like cells that penetrate solid tumors and blood cancers
10:30 AM
    • Oncology
    Franciscan C
    Bexion is a clinical stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy. The Company’s lead ass ...
    • Ophthalmology
    Franciscan D
    Caeregen is a breakthrough regenerative medicine therapeutics company targeting neurosensory diseases, with a revolutionary first drug, CTR-107 (Noregen), for vision loss and blindness from retinal d ...
    • CNS/Neurological
    Franciscan B
    Company Description: Aruna’s AB126, a therapeutic exosome, is an innovative neural anti-inflammatory and neuromodulator that naturally crosses the blood-brain-barrier. Using exosomes from neural stem ...
10:45 AM
    • Gene/Cell Therapy
    Franciscan B
    Aegle Therapeutics is a clinical stage biotech company with a platform technology focused on rare diseases. Aegle first product, AGLE-102, is a compositive of nanoparticles called extracellular vesicl ...
    • Oncology
    Franciscan C
    Biofidelity is a rapidly-growing commercial-stage genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world. ASPYRE®, the first application of ou ...
    • Ophthalmology
    Franciscan D
    Epion Therapeutics (Epion) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart™, its transformativ ...
11:00 AM
    • Gene/Cell Therapy
    Franciscan B
    Coastar Therapeutics is a San Diego based company focusing on systemic gene delivery technology. The company has developed a novel ENHEnS technology that can coat human cell membrane on each individua ...
    • Respiratory
    Franciscan D
    Advagene is a discovery company focuses on immunotherapy and intranasal vaccine for respiratory hypersensitivity and infection. The LTh(αK), intellectual property owned by Advagene, is developed by th ...
    • Oncology
    Franciscan C
    Company Description: Cellworks Group, Inc. is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients an ...
11:15 AM
    • Gene/Cell Therapy
    Franciscan B
    The mission of CDR3 is to develop a curative stem cell gene immunotherapy, delivering chimeric antigen receptors (CARs) or T cell receptors (TCRs) to treat chronic viral infections and virus-associate ...
    • Respiratory
    Franciscan D
    Inhalon Biopharma is a clinical-stage biotechnology company developing faster-acting, more effective, self-administered inhaled treatments to address the over $40B worldwide unmet need for patients su ...
    • Oncology
    Franciscan C
    Rakuten Medical is a private biotechnology firm that is developing cancer therapies with the ability to target cancer cells and induce immunogenic cell death, using a photoimmunotherapy platform with ...
11:30 AM
    • Gene/Cell Therapy
    Franciscan B
    Company Description: Celosia Therapeutics is a late discovery / early pre-clinical phase gene therapy company that is changing the paradigm for treatment for neurodegenerative disease. This is achieve ...
    • Respiratory
    Franciscan D
    Company Description: Donovan B. Yeates, Ph.D., Founder and CEO, KAER Biotherapeutics Corporation is introducing a two new game-changing product line, AeroPulsR. This device enables aqueous liquid surf ...
    • Oncology
    Franciscan C
    Company Description: Tundra Targeted Therapeutics develops bispecific antibodies to treat difficult cancers. The lead candidate targets leukemia and lymphoma by harnessing and activating a patient’s o ...
11:45 AM
    • Oncology
    Franciscan C
    Jaguar Health is a commercial stage pharmaceuticals company that develops novel, plant-based, sustainably derived prescription medicines for GI distress. Our Mytesi® (crofelemer) product (tablet) is F ...
    • Gene/Cell Therapy
    Franciscan B
    Company Description: OmniSpirant was founded by Mr Gerry McCauley, a pharmacist, and inventor of the first-in-class inhaled regenerative gene therapy platform technology (OmniSomes). OmniSpirant ident ...
    • Cardiovascular
    Franciscan D
    Company Description: KaloCyte is a pre-clinical biotech therapeutic startup company developing ErythroMer, a bioengineered artificial red blood cell (RBC) substitute that can be freeze-dried for long- ...

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS